Skip to content

OMDA OMDA Additional Paid-In Capital

Additional Paid-In Capital at other companies

Teladoc Health logo
Teladoc HealthTDOC
$17.87B+0.4%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$1.51B+9.3%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$1.4B+5.0%
Insulet logo
InsuletPODD
$1.28B+1.6%
AdaptHealth logo
AdaptHealthAHCO
$2.18B+0.9%
Eli Lilly logo
Eli LillyLLY
$6.92B+0.2%

Other financials

Income statement

See full
Revenue$78.0M+42.0%
Gross profit$48.7M+52.6%
Operating income-$4.8M+43.1%
Net income-$3.0M+68.6%
EPS (diluted)-$0.05+95.7%

Balance sheet

See full
Cash & equivalents$211.8M+257%
Total debt$30.0M
Total equity$234.1M+160%
Total assets$302.8M

Cash flow

See full
Operating cash flow-$11.8M+26.6%
CapEx$78.0K-75.2%
Free cash flow-$11.9M+27.5%

Valuation

See full
Market cap$1.11B+23.8%
P/S3.9×-0.4×

Profitability

See full
Gross margin66.3%+4.4pp
Operating margin-9.6%-4.0pp
Net margin-11.3%-4.6pp
FCF margin-40.8%

Returns & leverage

See full
Return on equity26.8%
Debt / equity0.1×
Current ratio3.9×

Where this comes from

Reported directly by OMDA in its filing.

Tagged under the XBRL concept us-gaap:AdditionalPaidInCapital.

The official record: OMDA’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about OMDA's additional paid-in capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OMDA's additional paid-in capital?
OMDA (OMDA) reported additional paid-in capital of $693.77M in Q1 2026.
What does additional paid-in capital mean?
Capital received from shareholders in excess of par value — the premium investors paid over the nominal value of shares at issuance, plus stock-based compensation effects.